Christophe Leclercq
Overview
Explore the profile of Christophe Leclercq including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
325
Citations
6381
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Frodi D, Boveda S, Fournier V, Kerkouri F, Anselme F, Deharo J, et al.
Arch Cardiovasc Dis
. 2025 Jan;
118(3):178-184.
PMID: 39890483
Background: Patient characteristics, technology and clinical practice surrounding primary prevention implantable cardioverter defibrillators have evolved continuously over time. Aim: To explore the temporal changes in patient characteristics, pharmacological therapy and...
2.
Lamirault G, Fellah-Hebia I, Chevalier C, Guisle I, Guyomarch B, Solnon A, et al.
J Mol Cell Cardiol Plus
. 2025 Jan;
8():100077.
PMID: 39802916
Heart failure (HF) increases the risk of developing atrial fibrillation (AF), leading to increased morbidity and mortality. Therefore, better prediction of this risk may improve treatment strategies. Although several predictors...
3.
Marc T, Benali K, Groussin P, Rakza R, Brito J, Behar N, et al.
Arch Cardiovasc Dis
. 2024 Nov;
118(1):35-42.
PMID: 39578210
Background: Following implantation/replacement of an implantable cardioverter-defibrillator, patients are legally subjected to variable lengths of driving restrictions based on the indication (1 and 3 months after primary and secondary prevention,...
4.
Gabet A, Lailler G, Fauchier L, Deharo J, Tuppin P, Leclercq C, et al.
Arch Cardiovasc Dis
. 2024 Nov;
117(12):693-704.
PMID: 39521645
Background: Heart rhythm and conduction disorders cover a variety of pathologies, ranging from the benign to the immediately life threatening. Aims: To describe the epidemiology of patients hospitalized for arrhythmias...
5.
Gaillard N, Deharo J, Suissa L, Defaye P, Sibon I, Leclercq C, et al.
Rev Neurol (Paris)
. 2024 Nov;
180(10):1000-1020.
PMID: 39510937
Atrial fibrillation (AF) is the primary cause of ischaemic stroke and transient ischaemic attack (TIA). AF is associated with a high risk of recurrence, which can be reduced using optimal...
6.
Martins R, Vlachos K, Cortez-Dias N, Groussin P, Rakza R, Behar N, et al.
Heart Rhythm
. 2024 Oct;
PMID: 39455034
Background: Ablation of infrequent premature ventricular complexes (PVC) is challenging. Objectives: A novel mapping strategy for patients with infrequent PVCs, called multielectrode catheter-induced ectopy mapping (MECIE mapping) is described, aiming...
7.
Klein C, Kouakam C, Lazarus A, de Groote P, Bauters C, Marijon E, et al.
Europace
. 2024 Oct;
26(10).
PMID: 39400005
Aims: Integrating remote monitoring (RM) into existing healthcare practice for heart failure (HF) patients to improve clinical outcome remains challenging. The ECOST-CRT study compared the clinical outcome of a comprehensive...
8.
Peek N, Hindricks G, Akbarov A, Tijssen J, Jenkins D, Kapacee Z, et al.
Eur Heart J
. 2024 Oct;
45(43):4616-4626.
PMID: 39378245
Background And Aims: Risk stratification of sudden cardiac death after myocardial infarction and prevention by defibrillator rely on left ventricular ejection fraction (LVEF). Improved risk stratification across the whole LVEF...
9.
Friedman P, Murgatroyd F, Boersma L, Manlucu J, Knight B, Clementy N, et al.
Circulation
. 2024 Sep;
151(4):322-332.
PMID: 39327797
Background: Substernal lead placement of the extravascular implantable cardioverter defibrillator (EV ICD) permits both defibrillation at thresholds similar to those seen with transvenous implantable cardioverter defibrillators and effective anti-tachycardia pacing...
10.
de Groote P, Thuny F, Blanchart K, Gueffet J, Habib G, Salvat M, et al.
Arch Cardiovasc Dis
. 2024 Sep;
117(11):624-632.
PMID: 39317620
Background: Previous studies have demonstrated the benefit of a haemodynamic-guided management strategy with the CardioMEMS™ HF System. No data from French patients have been published. Aims: To analyse the feasibility,...